Stage pT1 bladder carcinoma: Diagnostic criteria, pitfalls and prognostic significance

Pathology

Volumn 35, Issue 6, 2003, Pages 484-491

  Lopez Beltran, Antonio ^a,c   Cheng, Liang ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Universidad de Cordoba   (Spain)

Author keywords

Classification; Diagnostic criteria; Neoplasms; Prognosis; Stage pT1; Staging; Urinary bladder; Urothelial carcinoma

Indexed keywords

BLADDER CARCINOMA; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN; LAMINA PROPRIA; PROGNOSIS; REPRODUCIBILITY; REVIEW; TRANSURETHRAL RESECTION; UROTHELIUM;

EID: 0348047341     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020310001619127     Document Type: Article

References (52)

1. Droller MJ. Bladder cancer: State-of-the-art care. CA Cancer J Clin 1998; 48: 269-84.
2. Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 2000; 88: 2326-32.
3. Herr HW. Staging invasive bladder tumors. J Surg Oncol 1992; 51: 217-20.
4. Greene FL, Page DL, Flemming ID, et al. AJCC Cancer Staging Manual. New York: Springer-Verlag, 2002; 337-46.
5. Lopez-Beltran A, Sauter G, Gasser T, et al. Urothelial tumors: infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn I, editors. Pathology and genetics of tumors of the urinary system and male genital organs. Lyon: IARC Press, 2003.
6. Abel PD, Hall RR, Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 1988; 62: 235-9.
7. Malmstrom P, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patients with ≥ 5-year followup. Scand J Urol Nephrol 1987; 21: 185-95.
8. Montironi R, Lopez-Beltran A, Mazzuchelli R, Bostwick DG. Classification and grading of the non-invasive neoplasms: recent advances and controversies. J Clin Pathol 2003; 56: 91-5.
9. Bostwick DG, Ramnani DM, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin Nth Am 1999; 26: 493-507.
10. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The Bladder Consensus Conference Committee. The World Health Organisation/ International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435-8.
11. Esrig D, Freeman JA, Stein JP, Skinner DG. Early cystectomy for clinical stage pT1 transitional cell carcinoma of the bladder. Semin Urol Oncol 1997; 15: 154-160.
12. Lopez-Beltran A, Bollito E, Luque RJ, Montironi R. A practical approach to bladder sampling and diagnostic reporting of pathological findings. Pathologica 2001; 93: 688-92.
13. Jimenez RE, Keany TE, Hardy HT, Amin MB. pPT1 Urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol 2000; 7: 13-25.
14. Reuter V. Bladder: Risk and prognostic factors - a pathologist's perspective. Urol Clin Nth Am 1999; 26: 481-92.
15. Pathologists of the French Association of Urology Cancer Committee Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach. World J Urol 1993; 11: 161-4.
16. Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, pT1 urothelial carcinoma of the bladder. J Urol 1992; 169: 1291-4.
17. Tosoni I, Wagner U, Sauter G, et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000; 85: 48-53.
18. Bayraktar Z, Gurbuz G, Ihsan AT, Sevin G. Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy. Int J Urol Nephrol 2002; 33: 627-9.
19. Dalbagni G, Herr HW, Reuter VE. Impact of a second transurethral resection on the staging of PT1 bladder cancer. Urology 2002; 60: 822-4.
20. Pagano FAG, Milani C, Bassi P, Pegoraro V. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Eur Urol 1987; 13: 145-9.
21. Sozen S, Akbal C, Sokmensuer C, Ekici S, Ozen H. Microstaging of pPT1 transitional cell carcinoma of the bladder: does it really differentiate two populations with different prognoses? Urol Int 2002; 69: 200-6.
22. van der Meijden A, Sylvester L, Collette L, Bono A, ten Kate F. The role and impact of pathology review on stage and grade assessment of stages Ta and PT1 bladder tumors: a combined analysis of 5 European organization for research and treatment of cancer trials. J Urol 2000; 164: 1533-7.
23. Miladi M, Peyromaure M, Zerbib M, Saighi D, Debre B. The value of a second transurethral resection in evaluating patients with bladder tumors. Eur Urol 2003; 43: 241-5.
24. Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Am J Clin Pathol 2000; 113: 275-9.
25. Mhawech P, Iselin C, Pelte MF. Value of immunohistochemistry in staging PT1 urothelial bladder carcinoma. Eur Urol 2002; 42: 459-63.
26. Amin MB, Ro JY, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994; 18: 1224-32.
27. Bostwick DG, Lopez-Beltran A. Bladder Biopsy Interpretation. Washington DC: UPP, 1999.
28. Lopez-Beltran A, Cheng L, Andersson L, et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch 2002; 440: 3-11.
29. Cheng L, Cheville JC, Leibovich BC, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999; 85: 2469-74.
30. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999; 23: 443-7.
31. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Flat intra-epithelial lesions of the urinary bladder. Cancer 2000; 88: 625-31.
32. Farrow GM, Utz DC. Observation on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol 1982; 1: 609-15.
33. Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997; 21: 1057-68.
34. McKenney JK, Gomez J, Desai S, Lee MW, Amin MB. Morphologic expressions of urothelial carcinoma in situ. Am J Surg Pathol 2001; 25: 356-62.
35. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999; 17: 3182-7.
36. Cheng L, Weaver AL, Neumann RM, Schere BG, Bostwick DG. Substaging of PT1 bladder carcinoma based on the depth of invasion measured by micrometer: a new proposal. Cancer 1999; 86: 1035-43.
37. Cheng L, Weaver AL, Bostwick DG. Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens. Urology 2000; 55: 668-72.
38. Cheng L, Neumann RM, Scherer BG, et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999; 85: 2638-47.
39. Lopez-Beltran A. Bladder treatment. Immunotherapy and Chemotherapy. Urol Clin Nth Am 1999; 26: 535-54.
40. Lopez-Beltran A, Luque RJ, Mazzuchelli R, Scarpelli M, Montironi R. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol 2002; 55: 641-7.
41. Eble JN, Young RH. Carcinoma of the urinary bladder: a review of its diverse morphology. Semin Diagn Pathol 1997; 14: 98-108.
42. Drew PA, Furman J, Civantos F, Murphy WM. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996; 9: 989-94.
43. Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M. Muscularis mucosa differentiates two populations with different prognosis in stage PT1 bladder cancer. Urology 1995; 45: 47-53.
44. Hasui Y, Osada Y, Kitada S, Nishi S. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994; 43: 782-6.
45. Hermann GG, Horn T, Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage PT1 transitional cell bladder cancer. J Urol 1998; 159: 91-4.
46. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage Tl bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800-4.
47. Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 11: 1035-9.
48. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66: 543-8.
49. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae. J Anat 1983; 136: 265-71.
50. Ro JY, Ayala AG, El-Naggar A. Muscularis mucosa of urinary bladder. Am J Surg Pathol 1987; 11: 668-73.
51. Keep JC, Piehl M, Miller A, Oyasu R. Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 1989; 91: 575-9.
52. Engel P, Anagnostaki L, Braendstrup O. The muscularis mucosae of the human urinary bladder. Scand J Urol Nephrol 1992; 26: 249-52.